IMM 3.13% 31.0¢ immutep limited

News: IMM Immutep Announces First Participant Dosed In Phase I Study Of Imp761, page-22

  1. 2,625 Posts.
    lightbulb Created with Sketch. 326
    AUGUST 23RD 2024Bell Potter - Looking out for two LAG-3 ESMO Presentations; Maintain Buy, A$0.75 (Analyst: Thomas Wakim)
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.